to experience the full functionality of mail.com.
Enhanced by Google
April 28, 2016
Shareholders criticize Pfizer after scrapped Allergan deal
Just weeks after the collapse of Pfizer's controversial deal to buy fellow drugmaker Allergan and move its headquarters to ...
April 27, 2016
Pfizer agrees to $785M settlement in drug discount case
Drugmaker Pfizer Inc. has agreed to pay nearly $785 million to resolve allegations that one of its companies failed to give ...
April 22, 2016
Study: No suicide risk for anti-smoking pills Chantix, Zyban
Seven years after U.S. regulators slapped their strictest warning on two popular smoking-cessation medicines citing risks of ...
April 13, 2016
Napster co-founder bankrolls project to speed cancer work
A project to speed development of cancer-fighting drugs that harness the immune system has academic and drug industry ...
April 07, 2016
Global stocks turn lower as oil rally fades
Stocks are opening lower in the U.S. as corporate earnings reports start to trickle in. Investors have low expectations for ...
April 06, 2016
Asian stocks mixed after Wall Street, oil gains
Asian stock markets were mixed Thursday after Wall Street rebounded from a losing streak and oil prices surged.
April 05, 2016
FDA approves 1st cheaper version of J&J's top drug Remicade
Federal health officials have approved a cheaper version of Johnson & Johnson's blockbuster drug, Remicade, a pricey biotech ...
April 05, 2016
Obama praises Treasury steps to deter 'tax inversions'
President Barack Obama on Tuesday championed new federal steps to discourage corporate tax dodging through a practice known ...
April 05, 2016
Allergan continues to slide on new tax inversion rules
Allergan's stock is down 20 percent with the U.S. aggressively pushing its campaign to shut down so-called tax inversions by ...
April 04, 2016
Treasury Department sets its sights against inversions
The Treasury Department announced a new package of rules Monday aimed at making "tax inversions" — when U.S. companies move ...
March 17, 2016
Trump faces obstacles in bid to shake up corporate America
Donald Trump's railing about what's wrong in corporate America goes further than the typical political populism: He vows to ...
March 12, 2016
MSF challenges Pfizer's India vaccine patent application
Doctors Without Borders has challenged Pfizer's application for an Indian patent for its pneumonia vaccine so cheaper ...
March 11, 2016
FDA expands use of Pfizer drug for rare form of lung cancer
The Food and Drug Administration expanded approval of a Pfizer drug to treat a small subset of lung cancer patients with a ...
February 16, 2016
Pfizer adds $784.6 M charge for Protonix deal to 4Q results
Drugmaker Pfizer Inc. swung to a fourth-quarter financial loss, instead of a modest profit, as a result of a just-announced ...
February 08, 2016
Senator scrutinizes pharma links on government pain panel
A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently ...
February 02, 2016
Pfizer earnings fall but tops Street 4Q forecasts
Pfizer Inc.'s fourth-quarter profit fell by half due to higher costs for production, administration and restructuring, but ...
January 11, 2016
Irish drugmaker Shire in $32B deal for US-based Baxalta
Irish drugmaker Shire PLC's second attempt to buy Baxalta looks more likely to succeed, with Baxalta's board backing the ...
January 06, 2016
Correction: Financial Markets-The Year in Deals story
In a story Dec. 31 about global deals, The Associated Press reported erroneously that Dow DuPont's products will include ...
January 04, 2016
First-of-a-kind drug approvals continued rise in 2015
Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 ...
December 11, 2015
FDA approves Genentech drug for advanced lung cancer
The Food and Drug Administration on Friday conditionally approved an experimental Genentech drug for patients with a certain ...